Findings

What do systematic reviews say?

14 questions · 14 findings · 2 reviews · Schizophrenia · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 14.3%GRADE not reported 3 · 21.4%Very low 7 · 50%Low 2 · 14.3%Moderate 0 · 0%High 0 · 0%

NIDOTHERAPY‐ENHANCED STANDARD CARE vs usual care

Social functioning · schizophrenia

1 finding from 1 review

Nidotherapy for people with schizophrenia 2013 · Cochrane Headline outcomes only
no estimate extracted
1 study · 37 participants
Very low

NIDOTHERAPY‐ENHANCED STANDARD CARE vs usual care

General functioning ‐ no clinically important change in general functioning · schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Nidotherapy for people with schizophrenia 2013 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

NIDOTHERAPY‐ENHANCED STANDARD CARE vs usual care

Clinical response: no clinically significant response in mental state · schizophrenia

1 finding from 1 review

Nidotherapy for people with schizophrenia 2013 · Cochrane Headline outcomes only
no estimate extracted
1 study · 37 participants
Low

NIDOTHERAPY‐ENHANCED STANDARD CARE vs usual care

Quality of life: no significant change in quality of life/satisfaction medium term (3‐12 months) not reported · schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Nidotherapy for people with schizophrenia 2013 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

NIDOTHERAPY‐ENHANCED STANDARD CARE vs usual care

Satisfaction with treatment · schizophrenia

1 finding from 1 review

Nidotherapy for people with schizophrenia 2013 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

NIDOTHERAPY‐ENHANCED STANDARD CARE vs usual care

Economic outcomes ‐ total costs (12 months) NHS Reference Costs and unit costs · schizophrenia

1 finding from 1 review

Nidotherapy for people with schizophrenia 2013 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 1 participants
Low

NIDOTHERAPY‐ENHANCED STANDARD CARE vs usual care

Adverse effect: Specific ‐ Death · schizophrenia

It is very uncertain whether NIDOTHERAPY‐ENHANCED STANDARD CARE changes adverse effects ‐ specific ‐ death Number of individual deaths of… compared with STANDARD CARE (very low certainty).

1 finding from 1 review

Nidotherapy for people with schizophrenia 2013 · Cochrane Headline outcomes only
RR 0.29 [0.01, 6.74]
1 study · 52 participants
Very low

Group C other: family treatment vs enhanced care

Prodromal symptoms: transition to psychosis FACT Long‐term · people in the prodromal stage of psychosis

It is very uncertain whether group C other: family treatment changes prodromal symptoms: transition to psychosis FACT Long‐term compared with enhanced care (very low certainty).

1 finding from 1 review

Interventions for prodromal stage of psychosis 2019 · Cochrane Headline outcomes only
RR 0.71 [0.35, 1.45]
1 study · 100 participants
Very low

Group C other: family treatment vs enhanced care

Global state: antipsychotic prescriptions (events) · people in the prodromal stage of psychosis

It is very uncertain whether group C other: family treatment changes global state: antipsychotic prescriptions (events) compared with enhanced care (very low certainty).

1 finding from 1 review

Interventions for prodromal stage of psychosis 2019 · Cochrane Headline outcomes only
RR 1.18 [0.69, 2.02]
1 study · 129 participants
Very low

Group C other: family treatment vs enhanced care

Mental state: specific ‐ psychosis risk, positive symptoms Average total score, SOPS positive (higher score = worse, scale from 0‐30) Short‐term · people in the prodromal stage of psychosis

1 finding from 1 review

Interventions for prodromal stage of psychosis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 102 participants
Very low

Group C other: family treatment vs enhanced care

Behaviour: clinically important change in behaviour · people in the prodromal stage of psychosis

1 finding from 1 review

Interventions for prodromal stage of psychosis 2019 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Group C other: family treatment vs enhanced care

Suicide · people in the prodromal stage of psychosis

It is very uncertain whether group C other: family treatment changes adverse events: suicide (events) Long‐term (by 24 months) compared with enhanced care (very low certainty).

1 finding from 1 review

Interventions for prodromal stage of psychosis 2019 · Cochrane Headline outcomes only
RR 1 [0.06, 15.55]
1 study · 100 participants
Very low

Group C other: family treatment vs enhanced care

Quality of life: clinically important change in quality of life · people in the prodromal stage of psychosis

1 finding from 1 review

Interventions for prodromal stage of psychosis 2019 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Group C other: family treatment vs enhanced care

Satisfaction with treatment: leaving the study early FACT Long‐term · people in the prodromal stage of psychosis

It is very uncertain whether group C other: family treatment changes satisfaction with treatment: leaving the study early FACT Long‐term compared with enhanced care (very low certainty).

1 finding from 1 review

Interventions for prodromal stage of psychosis 2019 · Cochrane Headline outcomes only
RR 0.94 [0.52, 1.68]
1 study · 100 participants
Very low